Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$19.2M Buy
72,067
+1,916
+3% +$519K 0.03% 406
2025
Q4
$17.6M Buy
70,151
+3,759
+6% +$998K 0.03% 422
2025
Q3
$19.1M Buy
66,392
+3,919
+6% +$1.05M 0.03% 394
2025
Q2
$16.4M Buy
62,473
+3,090
+5% +$752K 0.03% 410
2025
Q1
$13.8M Buy
59,383
+8,893
+18% +$2.16M 0.03% 401
2024
Q4
$11.6M Buy
50,490
+9,602
+23% +$2.2M 0.03% 416
2024
Q3
$9.14M Buy
40,888
+757
+2% +$166K 0.02% 428
2024
Q2
$8.17M Sell
40,131
-1,411
-3% -$287K 0.02% 460
2024
Q1
$9.08M Sell
41,542
-16,897
-29% -$3.72M 0.03% 459
2023
Q4
$13.3M Sell
58,439
-24,901
-30% -$5.23M 0.05% 404
2023
Q3
$16.8M Sell
83,340
-32,832
-28% -$6.93M 0.07% 350
2023
Q2
$24.1M Sell
116,172
-41,003
-26% -$7.95M 0.1% 253
2023
Q1
$31M Buy
157,175
+30,235
+24% +$6.22M 0.14% 201
2022
Q4
$25.7M Buy
126,940
+52,662
+71% +$10.3M 0.13% 216
2022
Q3
$13.1M Buy
74,278
+17,974
+32% +$3.68M 0.08% 364
2022
Q2
$11.3M Buy
56,304
+32,712
+139% +$6.97M 0.06% 415
2022
Q1
$5.34M Sell
23,592
-20,262
-46% -$4.77M 0.03% 584
2021
Q4
$11.8M Buy
43,854
+3,026
+7% +$749K 0.05% 365
2021
Q3
$9.87M Buy
40,828
+4,259
+12% +$1.07M 0.04% 400
2021
Q2
$8.67M Sell
36,569
-1,090
-3% -$248K 0.04% 432
2021
Q1
$8.25M Buy
37,659
+367
+1% +$73.7K 0.04% 389
2020
Q4
$6.52M Buy
37,292
+813
+2% +$140K 0.03% 427
2020
Q3
$5.9M Sell
36,479
-998
-3% -$158K 0.03% 409
2020
Q2
$5.35M Sell
37,477
-2,111
-5% -$292K 0.03% 409
2020
Q1
$4.3M Sell
39,588
-340
-0.9% -$49K 0.03% 441
2019
Q4
$5.8M Sell
39,928
-369
-0.9% -$53.3K 0.04% 424
2019
Q3
$5.82M Sell
40,297
-2,934
-7% -$428K 0.04% 380
2019
Q2
$6.42M Sell
43,231
-964
-2% -$135K 0.04% 380
2019
Q1
$5.81M Sell
44,195
-47
-0.1% -$5.79K 0.04% 410
2018
Q4
$4.8M Sell
44,242
-12,986
-23% -$1.74M 0.04% 430
2018
Q3
$8.54M Sell
57,228
-31,627
-36% -$4.81M 0.05% 369
2018
Q2
$13.7M Buy
88,855
+28,207
+47% +$4.26M 0.08% 251
2018
Q1
$8.43M Sell
60,648
-5,252
-8% -$771K 0.05% 346
2017
Q4
$9.03M Sell
65,900
-9,454
-13% -$1.25M 0.05% 354
2017
Q3
$9.77M Buy
75,354
+419
+0.6% +$55.9K 0.05% 354
2017
Q2
$9.92M Buy
74,935
+1,222
+2% +$150K 0.06% 355
2017
Q1
$9.09M Sell
73,713
-4,289
-5% -$508K 0.05% 362
2016
Q4
$8.6M Buy
78,002
+5,529
+8% +$614K 0.05% 378
2016
Q3
$8.56M Buy
72,473
+1,675
+2% +$197K 0.05% 385
2016
Q2
$7.92M Buy
70,798
+10,957
+18% +$1.18M 0.05% 362
2016
Q1
$6.02M Buy
59,841
+1,244
+2% +$119K 0.04% 430
2015
Q4
$6.22M Sell
58,597
-168
-0.3% -$17.3K 0.05% 412
2015
Q3
$5.48M Buy
58,765
+743
+1% +$76.9K 0.05% 439
2015
Q2
$6.04M Sell
58,022
-4,377
-7% -$456K 0.04% 436
2015
Q1
$6.76M Buy
62,399
+21,126
+51% +$2.17M 0.05% 440
2014
Q4
$3.83M Sell
41,273
-245
-0.6% -$21.6K 0.03% 558
2014
Q3
$3.63M Sell
41,518
-174
-0.4% -$15.7K 0.03% 582
2014
Q2
$3.67M Sell
41,692
-512
-1% -$44.4K 0.03% 580
2014
Q1
$3.56M Buy
42,204
+570
+1% +$45.5K 0.03% 565
2013
Q4
$3.27M Buy
41,634
+254
+0.6% +$21.7K 0.03% 584
2013
Q3
$3.52M Buy
41,380
+7,728
+23% +$651K 0.03% 524
2013
Q2
$2.89M Buy
+33,652
New +$2.79M 0.03% 499

Other funds holding LH

Aviva's LH Position: Q1 2026 in Review

Aviva increased its Labcorp (LH) stake by 2.7% in Q1 2026, buying an estimated $519K and bringing the position to 72,067 shares worth $19.2M. The position accounts for 0.03% of the portfolio, ranked #406.

Aviva first reported a position in LH in Q2 2013 and has held it in 52 quarters since. The position peaked at $31M in Q1 2023. 1,031 funds tracked by Wall St. Rank hold LH as of Q1 2026.

  • Aviva held 72,067 shares of Labcorp worth $19.2M as of Q1 2026.
  • Aviva bought 1,916 Labcorp shares in Q1 2026, an estimated $519K.
  • Labcorp made up 0.03% of Aviva's portfolio in Q1 2026, its #406 holding.
  • Aviva first reported a position in Labcorp in Q2 2013 and has held it in 52 quarters since.
  • Aviva's Labcorp position peaked at $31M in Q1 2023.
  • 1,031 funds tracked by Wall St. Rank held Labcorp as of Q1 2026.

Based on Aviva's 13F filing for Q1 2026, filed 14 May 2026.